BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 28 filers reported holding BURNING ROCK BIOTECH LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $36,519 | -80.0% | 16,752 | -74.2% | 0.00% | -100.0% |
| Q1 2023 | $182,150 | -5.1% | 64,822 | -24.0% | 0.00% | 0.0% |
| Q4 2022 | $191,891 | -7.3% | 85,285 | -1.6% | 0.00% | 0.0% |
| Q3 2022 | $207,000 | -20.7% | 86,715 | -3.3% | 0.00% | 0.0% |
| Q2 2022 | $261,000 | -82.3% | 89,694 | -43.4% | 0.00% | -83.3% |
| Q1 2022 | $1,472,000 | -20.2% | 158,413 | -18.2% | 0.01% | -45.5% |
| Q4 2021 | $1,845,000 | -34.8% | 193,596 | +22.4% | 0.01% | -26.7% |
| Q3 2021 | $2,829,000 | +182.9% | 158,195 | +365.9% | 0.02% | +150.0% |
| Q2 2021 | $1,000,000 | – | 33,957 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 217,728 | $5,030,000 | 2.29% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,685,908 | $38,944,000 | 2.07% |
| Casdin Capital, LLC | 1,922,150 | $44,402,000 | 1.32% |
| Orbimed Advisors | 4,161,675 | $96,135,000 | 0.84% |
| INDUS CAPITAL PARTNERS, LLC | 144,580 | $3,340,000 | 0.52% |
| Aspex Management (HK) Ltd | 486,418 | $11,236,000 | 0.44% |
| HSG Holding Ltd | 212,121 | $4,900,000 | 0.41% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 15,100 | $349,000 | 0.39% |
| HAMILTON LANE ADVISORS LLC | 44,416 | $1,026,000 | 0.38% |
| Monashee Investment Management LLC | 80,000 | $1,848,000 | 0.24% |